Immunological patterns identifying disease course and evolution in multiple sclerosis patients

Journal of Neuroimmunology

Volumn 165, Issue 1-2, 2005, Pages 192-200

  Furlan, Roberto ^a   Rovaris, Marco ^a   Boneschi, Filippo Martinelli ^a   Khademi, Mohsen ^b   Bergami, Alessandra ^a   Gironi, Maira ^a   Deleidi, Michela ^a   Agosta, Federica ^a   Franciotta, Diego ^c   Scarpini, Elio ^d   Uccelli, Antonio ^e   Zaffaroni, Mauro ^f   Kurne, Asli ^a   Comi, Giancarlo ^a   Olsson, Tomas ^b   Filippi, Massimo ^a   Martino, Gianvito ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e UNIVERSITY OF GENOA   (Italy)

^f Azienda Ospedaliera S Antonio Abate di Gallarate   (Italy)

Author keywords

Chemokines; Cytokines; Multiple sclerosis; Multivariate analysis; Real time RT PCR

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CXCR5; CYTOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; INTERLEUKIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MESSENGER RNA; RANTES; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MOLECULE; MULTIPLE SCLEROSIS; MULTIVARIATE ANALYSIS; PATIENT; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RECURRENT DISEASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; STATISTICAL ANALYSIS;

ADULT; BIOLOGICAL MARKERS; CHEMOKINES, CC; DISEASE PROGRESSION; FEMALE; HUMANS; INTERLEUKIN-1; LINEAR MODELS; MACROPHAGE INFLAMMATORY PROTEINS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MODELS, IMMUNOLOGICAL; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MULTIVARIATE ANALYSIS; RECEPTORS, CHEMOKINE; RECEPTORS, CYTOKINE; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 22144434812     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2005.04.012     Document Type: Article

References (39)

1. G. Acar, F. Idiman, G. Kirkali, S. Ozakbas, G. Oktay, H. Cakmakci, and E. Idiman Intrathecal sICAM-1 production in multiple sclerosis. Correlation with triple dose Gd-DTPA MRI enhancement and IgG index J. Neurol. 252 2005 146 150
2. E. Ambrosini, S. Columba-Cabezas, B. Serafini, A. Muscella, and F. Aloisi Astrocytes are the major intracerebral source of macrophage inflammatory protein-3alpha/CCL20 in relapsing experimental autoimmune encephalomyelitis and in vitro Glia 41 2003 290 300
3. A. Bar-Or, R.K. Nuttall, M. Duddy, A. Alter, H.J. Kim, I. Ifergan, C.J. Pennington, P. Bourgoin, D.R. Edwards, and V.W. Yong Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis Brain 126 2003 2738 2749
4. M.J. Eikelenboom, J. Killestein, T. Izeboud, N.F. Kalkers, R.A. van Lier, F. Barkhof, B.M. Uitdehaag, and C.H. Polman Chemokine receptor expression on T cells is related to new lesion development in multiple sclerosis J. Neuroimmunol. 133 2002 225 232
5. M. Filippi Predictive value of MRI findings in multiple sclerosis Lancet Neurol. 1 2002 9
6. D. Franciotta, G. Martino, E. Zardini, R. Furlan, R. Bergamaschi, L. Andreoni, and V. Cosi Serum and CSF levels of MCP-1 and IP-10 in multiple sclerosis patients with acute and stable disease and undergoing immunomodulatory therapies J. Neuroimmunol. 115 2001 192 198
7. Y. Galboiz, and A. Miller Immunological indicators of disease activity and prognosis in multiple sclerosis Curr. Opin. Neurol. 15 2002 233 237
8. D. Giunti, G. Borsellino, R. Benelli, M. Marchese, E. Capello, M.T. Valle, E. Pedemonte, D. Noonan, A. Albini, G. Bernardi, G.L. Mancardi, L. Battistini, and A. Uccelli Phenotypic and functional analysis of T cells homing into the CSF of subjects with inflammatory diseases of the CNS J. Leukoc. Biol. 73 2003 584 590
9. B. Hemmer, J.J. Archelos, and H.P. Hartung New concepts in the immunopathogenesis of multiple sclerosis Nat. Rev., Neurosci. 3 2002 291 301
10. T.O. Jalonen, K. Pulkkinen, M. Ukkonen, M. Saarela, and I. Elovaara Differential intracellular expression of CCR5 and chemokines in multiple sclerosis subtypes J. Neurol. 249 2002 576 583
11. S. Kastenbauer, U. Koedel, M. Wick, B.C. Kieseier, H.P. Hartung, and H.W. Pfister CSF and serum levels of soluble fractalkine (CX3CL1) in inflammatory diseases of the nervous system J. Neuroimmunol. 137 2003 210 217
12. M. Kerschensteiner, C. Stadelmann, G. Dechant, H. Wekerle, and R. Hohlfeld Neurotrophic cross-talk between the nervous and immune systems: implications for neurological diseases Ann. Neurol. 53 2003 292 304
13. B.C. Kieseier, and H.P. Hartung Current disease-modifying therapies in multiple sclerosis Semin. Neurol. 23 2003 133 146
14. R.E. Kohler, A.C. Caon, D.O. Willenborg, I. Clark-Lewis, and S.R. McColl A role for macrophage inflammatory protein-3 alpha/CC chemokine ligand 20 in immune priming during T cell-mediated inflammation of the central nervous system J. Immunol. 170 2003 6298 6306
15. B. Kornek, and H. Lassmann Neuropathology of multiple sclerosis-new concepts Brain Res. Bull. 61 2003 321 326
16. F.D. Lublin, and S.C. Reingold Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis Neurology 46 1996 907 911
17. D.J. Mahad, S.J. Howell, and M.N. Woodroofe Expression of chemokines in cerebrospinal fluid and serum of patients with chronic inflammatory demyelinating polyneuropathy J. Neurol. Neurosurg. Psychiatry 73 2002 320 323
18. K. Makhlouf, H.L. Weiner, and S.J. Khoury Increased percentage of IL-12+ monocytes in the blood correlates with the presence of active MRI lesions in MS J. Neuroimmunol. 119 2001 145 149
19. E.M. Martinez-Caceres, C. Espejo, L. Brieva, I. Pericot, M. Tintore, I. Saez-Torres, and X. Montalban Expression of chemokine receptors in the different clinical forms of multiple sclerosis Mult. Scler. 8 2002 390 395
20. G. Martino, L. Adorini, P. Rieckmann, J. Hillert, B. Kallmann, G. Comi, and M. Filippi Inflammation in multiple sclerosis: the good, the bad, and the complex Lancet Neurol. 1 2002 499 509
21. J.N. Matthews, D.G. Altman, M.J. Campbell, and P. Royston Analysis of serial measurements in medical research BMJ 300 1990 230 235
22. W.I. McDonald, A. Compston, G. Edan, D. Goodkin, H.P. Hartung, F.D. Lublin, H.F. McFarland, D.W. Paty, C.H. Polman, S.C. Reingold, M. Sandberg-Wollheim, W. Sibley, A. Thompson, S. van den Noort, B.Y. Weinshenker, and J.S. Wolinsky Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis Ann. Neurol. 50 2001 121 127
23. D.H. Miller, F. Barkhof, I. Berry, L. Kappos, G. Scotti, and A.J. Thompson Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines J. Neurol. Neurosurg. Psychiatry 54 1991 683 688
24. T. Misu, H. Onodera, K. Fujihara, K. Matsushima, O. Yoshie, N. Okita, S. Takase, and Y. Itoyama Chemokine receptor expression on T cells in blood and cerebrospinal fluid at relapse and remission of multiple sclerosis: imbalance of Th1/Th2-associated chemokine signaling J. Neuroimmunol. 114 2001 207 212
25. J.H. Noseworthy, C. Lucchinetti, M. Rodriguez, and B.G. Weinshenker Multiple sclerosis N. Engl. J. Med. 343 2000 938 952
26. T. Olsson Cytokine-producing cells in experimental autoimmune encephalomyelitis and multiple sclerosis Neurology 45 1995 S11 S15
27. R.M. Ransohoff, P. Kivisakk, and G. Kidd Three or more routes for leukocyte migration into the central nervous system Nat. Rev., Immunol. 3 2003 569 581
28. T. Revesz, D. Kidd, A.J. Thompson, R.O. Barnard, and W.I. McDonald A comparison of the pathology of primary and secondary progressive multiple sclerosis Brain 117 Pt. 4 1994 759 765
29. C. Rodriguez-Sainz Mdel, S. Sanchez-Ramon, C. de Andres, M. Rodriguez-Mahou, and M.A. Munoz-Fernandez Th1/Th2 cytokine balance and nitric oxide in cerebrospinal fluid and serum from patients with multiple sclerosis Eur. Cytokine Netw. 13 2002 110 114
30. M. Rovaris, M. Filippi, G. Calori, M. Rodegher, A. Campi, B. Colombo, and G. Comi Intra-observer reproducibility in measuring new putative MR markers of demyelination and axonal loss in multiple sclerosis: a comparison with conventional T2-weighted images J. Neurol. 244 1997 266 270
31. N.R. Saunders, M.D. Habgood, and K.M. Dziegielewska Barrier mechanisms in the brain. I. Adult brain Clin. Exp. Pharmacol. Physiol. 26 1999 11 19
32. E. Scarpini, D. Galimberti, P. Baron, R. Clerici, M. Ronzoni, G. Conti, and G. Scarlato IP-10 and MCP-1 levels in CSF and serum from multiple sclerosis patients with different clinical subtypes of the disease J. Neurol. Sci. 195 2002 41 46
33. E. Sindern, T. Patzold, L.M. Ossege, A. Gisevius, and J.P. Malin Expression of chemokine receptor CXCR3 on cerebrospinal fluid T-cells is related to active MRI lesion appearance in patients with relapsing-remitting multiple sclerosis J. Neuroimmunol. 131 2002 186 190
34. T.L. Sorensen, H. Roed, and F. Sellebjerg Chemokine receptor expression on B cells and effect of interferon-beta in multiple sclerosis J. Neuroimmunol. 122 2002 125 131
35. T. Strunk, S. Bubel, B. Mascher, P. Schlenke, H. Kirchner, and K.P. Wandinger Increased numbers of CCR5+ interferon-gamma- and tumor necrosis factor-alpha-secreting T lymphocytes in multiple sclerosis patients Ann. Neurol. 47 2000 269 273
36. N. Teleshova, M. Pashenkov, Y.M. Huang, M. Soderstrom, P. Kivisakk, V. Kostulas, M. Haglund, and H. Link Multiple sclerosis and optic neuritis: CCR5 and CXCR3 expressing T cells are augmented in blood and cerebrospinal fluid J. Neurol. 249 2002 723 729
37. A.H. van Boxel-Dezaire, S.C. Hoff, B.W. van Oosten, C.L. Verweij, A.M. Drager, H.J. Ader, J.C. van Houwelingen, F. Barkhof, C.H. Polman, and L. Nagelkerken Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis Ann. Neurol. 45 1999 695 703
38. A.H. van Boxel-Dezaire, M. Smits, S.C. van Trigt-Hoff, J. Killestein, J.C. van Houwelingen, C.H. Polman, and L. Nagelkerken Cytokine and IL-12 receptor mRNA discriminate between different clinical subtypes in multiple sclerosis J. Neuroimmunol. 120 2001 152 160
39. H.Y. Wang, M. Matsui, S. Araya, N. Onai, K. Matsushima, and T. Saida Chemokine receptors associated with immunity within and outside the central nervous system in early relapsing-remitting multiple sclerosis J. Neuroimmunol. 133 2002 184 192